Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Domaco, Dr. med. Aufdermaur is a Swiss pharmaceutical company specializing in the development and manufacture of medicated lozenges, dietary supplements, and functional confectionery. Founded in 1922, the company operates as a leading Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) for the global healthcare and food industries. Their expertise lies in galenical formulations such as hard-boiled candies, pastilles, and instant teas, often incorporating herbal extracts and active pharmaceutical ingredients. Domaco is well-known for its proprietary brands like the "20-Herbs" candy and provides end-to-end services from formulation to final packaging. The company maintains high quality standards, including GMP and ISO certifications, to serve a diverse international clientele.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Domaco Dr. med. Aufdermaur.